Therefore, for optimal therapeutic targeting of RIPK3 in inflammatory diseases, such as arthritis, it will be important to carefully evaluate the bifurcation of RIPK3-induced necroptosis and DAMP-driven inflammation versus cell intrinsic-induced cytokine production and activation. The gene discussed is RIPK3; the disease is Arthritis.